Inspirna - The Future of Cancer Therapy
Mar 08, 2022 Inspirna Announces Phase 1b RGX-202 Clinical Trial Data Selected for Poster Presentation at the 2022 American Society of Clinical Oncology ASCO Annual Meeting. April 27, 2022 10:00 AM Eastern Daylight Time NEW YORK-- BUSINESS WIRE --Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small.
احصل على السعر